Abbott Laboratories Revenue 2007–2025
Abbott Laboratories annual/quarterly revenue history and growth rate from 2007 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Abbott Laboratories revenue for the quarter ending March 31, 2026 was 11.2 B, a 7.78% increase year-over-year.
- Abbott Laboratories revenue for the twelve months ending March 31, 2026 was 44.0 B, a 7.09% increase year-over-year.
- Abbott Laboratories annual revenue for 2025 was 44.3 B, a 5.67% increase from 2024.
- Abbott Laboratories annual revenue for 2024 was 42.0 B, a 4.59% increase from 2023.
- Abbott Laboratories annual revenue for 2023 was 40.1 B, a 8.12% decrease from 2022.
- Abbott Laboratories annual revenue for 2022 was 43.7 B.
Abbott Laboratories (ABT) — Frequently Asked Questions
Abbott Laboratories (ABT) is a publicly traded US company in the Healthcare sector. It has a market capitalization of $155.87B. In fiscal 2025 it reported revenue of $44.33B and net income of $6.52B. Explore ABT's stock price, financial statements, earnings history, margins and key ratios below.
What is Abbott Laboratories's market cap?
Abbott Laboratories (ABT) has a market capitalization of $155.87B.
What is the ABT stock price?
ABT trades at $89.17 (-2.28% on the day).
How much revenue does Abbott Laboratories make?
Abbott Laboratories reported revenue of $44.33B in fiscal 2025.
Is ABT profitable?
In fiscal 2025, Abbott Laboratories reported net income of $6.52B.
What is ABT's P/E ratio?
Based on diluted EPS, ABT has a price-to-earnings (P/E) ratio of about 24.0.